Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TTC 352

Next Previous
Drug Profile

TTC 352

Alternative Names: TTC-352

Latest Information Update: 02 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Illinois at Chicago
  • Developer TTC Oncology
  • Class 2 ring heterocyclic compounds; Antineoplastics; Benzene derivatives; Ethers; Fluorobenzenes; Phenols; Small molecules; Thiophenes
  • Mechanism of Action Estrogen receptor alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Breast cancer

Most Recent Events

  • 25 Apr 2025 Pharmacodynamics data from a preclinical studies in Cancer presented at the 116th Annual Meeting of the American Association for Cancer Research, 2025 (AACR-2025)
  • 28 Mar 2025 No recent reports of development identified for phase-I development in Breast-cancer(Metastatic disease, Second-line therapy or greater) in USA (PO, Capsule)
  • 03 Mar 2023 TTC 352 is still in phase I trials in Breast cancer (Metastatic disease, Second-line therapy or greater) in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top